1. Home
  2. PTCT vs MAIN Comparison

PTCT vs MAIN Comparison

Compare PTCT & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$69.14

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Main Street Capital Corporation

MAIN

Main Street Capital Corporation

HOLD

Current Price

$54.06

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
MAIN
Founded
1998
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.3B
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
PTCT
MAIN
Price
$69.14
$54.06
Analyst Decision
Buy
Hold
Analyst Count
17
7
Target Price
$80.65
$61.57
AVG Volume (30 Days)
915.0K
853.1K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
8.21%
EPS Growth
264.48
N/A
EPS
7.78
3.95
Revenue
$264,734,000.00
N/A
Revenue This Year
N/A
$6.27
Revenue Next Year
$19.30
$5.14
P/E Ratio
$8.71
$13.32
Revenue Growth
36.19
N/A
52 Week Low
$35.95
$47.00
52 Week High
$87.50
$67.77

Technical Indicators

Market Signals
Indicator
PTCT
MAIN
Relative Strength Index (RSI) 55.26 45.05
Support Level $64.00 N/A
Resistance Level $69.23 $59.24
Average True Range (ATR) 2.24 1.42
MACD 0.57 0.05
Stochastic Oscillator 81.53 57.67

Price Performance

Historical Comparison
PTCT
MAIN

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About MAIN Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.

Share on Social Networks: